BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2021
View Archived Issues
Engineered cartilage secretes anti-inflammatory drug
Read More
Evotec initiates clinical development of chikungunya antibody EVT-894
Read More
FDA clears IND application for SQZ AACs in patients with HPV-positive tumors
Read More
Promising phase I data presented for tau monoclonal antibody PNT-001
Read More
Virios announces collaboration to evaluate its IMC-1 antiviral in patients with IBS
Read More
Topline data from pivotal DERMIS-1 and -2 studies of ARQ-151 in plaque psoriasis
Read More
Phase II study of CTP-692 in schizophrenia does not meet primary or secondary endpoints
Read More
Noveome and WRAIR collaborate to develop ST-266 for traumatic brain injury
Read More
Sun Pharma Advanced Research describes new camptothecin derivative prodrugs
Read More
New anti-influenza compounds identified at Nanjing Zhengxiang Pharmaceuticals
Read More
New LRRK2 inhibitors discovered at E-Scape Bio
Read More
Pharmaleads patents neprilysin and aminopeptidase N inhibitors
Read More
Mobocertinib shows clinical benefit in patients with exon 20-mutated NSCLC
Read More
Compounds for treating hepatitis B infection identified at Enanta Pharmaceuticals
Read More
Interim phase I data for SCB-2019 reveal robust immune responses against SARS-CoV-2
Read More
T-DXd shows preliminary evidence of antitumor activity in metastatic HER2-overexpressing NSCLC
Read More
Ampio expands phase I trial of Ampion for COVID-19 respiratory distress based on early data
Read More
Prothena plans phase III study of birtamimab for patients with Mayo stage IV AL amyloidosis
Read More
CD40-targeting vaccine enhances T- and B-cell responses against HIV-1
Read More
Tiziana reports data from exploratory trial of nasally administered foralumab for COVID-19
Read More
Updated results presented from TRIDENT-1 study of repotrectinib
Read More
WCLC 2021: KRAS drugs may do best in tough subtype
Read More
Phase II trial of ensifentrine pMDI formulation in COPD meets lung function endpoints
Read More
Phase III study of sparsentan in FSGS achieves interim proteinuria endpoint
Read More
Immunovant pauses dosing in trials of IMVT-1401
Read More